AN2 Therapeutics, Inc. (ANTX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$4.79
+0.10%
Mkt Cap $131.53M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | — | — | — | -$0.24 | -$0.29 | -20.83% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.23 | -$0.31 | -34.78% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.31 | -$0.21 | +32.26% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.26 | -$0.35 | -34.62% | — | — |
| Q1 2025 Mar 25, 2025 | — | — | — | -$0.25 | -$0.25 | +0.00% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.37 | -$0.43 | -16.22% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.63 | -$0.48 | +23.81% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.61 | -$0.56 | +8.20% | — | — |
| Q1 2024 Mar 28, 2024 | — | $80.00K | — | -$0.71 | -$0.57 | +19.72% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.63 | -$0.65 | -3.17% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.85 | -$0.81 | +4.71% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.68 | -$0.79 | -16.18% | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | -$0.63 | -$0.61 | +3.17% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.59 | -$0.59 | +0.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.45 | -$0.53 | -17.78% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.52 | -$2.98 | -473.08% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | — | -$0.49 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.42 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.36 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.15 | — | — | — |